UMCG and LifeLines participate in European research for ADHD

Thursday 14 April 2016

Print this page

The UMCG is one of the seventeen European research institutes will participate in a research on the causes and consequences of ADHD. The aim is so to develop better treatment and possibly even prevent the disorder. The populationresearch  LifeLines provides data for the Groningen part of the investigation.

Research in Groningen
Researcher Catherine Hartman of the UMCG is project leader of the epidemiological part of the study and co-ordinates the study in Groningen. "The goal of our part of the large European study is to identify ADHD systematically, from childhood to old age. In several countries, we search for patterns of problems within families and the genetic background." LifeLines participants fill out a special questionnaire. The information obtained therefrom will be compared with figures from the other countries.

LifeLines is a large population study in the northern provinces of the Netherlands. It began to collect information for thirty years, started in 2006. The aim of the research is to learn more about healthy aging. The study has 165,000 participants.

ADHD stands for Attention Deficit Hyperactivity Disorder and begins in childhood. Little is known about ADHD at adults. According to the UMCG ADHD sometimes arises together with other psychiatric problems such as anxiety, depression, substance abuse and obesity. But it does not always. The UMCG therefore wants to find out what the reason is that it does not happen always. "Research on ADHD occurs almost exclusively in children under 12. It seems that people think that the problems after 12 subsequently disappear. The uniqueness of the present study is that we now can capture more about the development of ADHD develops in life," Hartman explains. "So that we hopefully learn more how the onset can be prevented and treated by additional problems in ADHD."

In Europe, more than 21 million people diagnosed with ADHD.